Hi Synapticians!

It’s official: The European Commission has just sent the forty-six CEOs calling for a two-year moratorium on the AI Act ; Airbus, Mistral, ASML and TotalEnergies chief among them ; back to their stopwatches. Despite their thunderous open letter, Brussels’ response fits in ten words: “There is no pause, full stop.”

Why the refusal?
First, because the timetable is now carved in legislative stone: the obligations for general-purpose AI (GPAI) models kick in August 2025, and those for “high-risk” systems follow in August 2026. Hitting the brakes now would mean reopening a text that has only just been adopted; a precedent the Commission has no interest in setting.

On substance, the worried bosses aren’t entirely wrong: delegated acts are late, the GPAI “Code of Practice” hasn’t been published, and SMEs fear a bureaucratic Everest. But Europe’s real risk would be to signal weakness: keep delaying and the standards will be set elsewhere. Silicon Valley and Shenzhen won’t wait for Brussels to “tidy its room.”

My wager? This hard line will cause some short-term teeth-grinding but pay off in the long run: regulatory clarity ⇢ investor confidence ⇢ a more attractive single market. The Commission is even preparing a digital paperwork spring-cleaning by end-2025; a smart compromise between rigour and pragmatism.

Spoiler: the Snooze button doesn’t exist in Brussels.

In short: Instead of freezing the clock, we need a lightning-fast push to finalise guidelines and technical road-maps. The countdown keeps ticking; it’s up to the European ecosystem to prove it’s fueling a rocket launch, not setting off a fire alarm.

Here’s the rest of the news about AI today:

• Google Faces EU Antitrust Over AI Summaries

• Isomorphic Labs' AI-Designed Drug Trials Begin

• AI Identifies Genetic Mutation After Decade

Top AI news

1. European Commission Rejects AI Act Moratorium Request
The European Commission has rejected a call for a two-year moratorium on the AI Act, despite concerns from major European companies about compliance timelines. Read online 🕶️

2. Google Faces EU Antitrust Over AI Summaries
Google's AI Overviews are under EU scrutiny for allegedly misusing web content, causing significant harm to publishers through traffic and revenue loss. Publishers can't opt out without disappearing from search results. Read online 🕶️

3. Isomorphic Labs' AI-Designed Drug Trials Begin
Isomorphic Labs, a Deepmind spin-off, is set to revolutionize drug development with AI-designed drugs using AlphaFold. First human trials are imminent, targeting cancer treatments. Read online 🕶️

4. AI Identifies Genetic Mutation After Decade
ChatGPT successfully identified a genetic MTHFR mutation after a decade of missed diagnoses, highlighting AI's role in complementing traditional medical care and offering new diagnostic insights. Read online 🕶️

Meme of the Day

Stay Connected

Feel free to contact us with any feedback or suggestions; we’d love to hear from you !